GW Henssler & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ATO
GW Henssler & Associates's MRK Position: Q2 2026 in Review
GW Henssler & Associates reduced its Merck (MRK) stake by 0.92% in Q2 2026, selling an estimated $195K and leaving 179,384 shares worth $23.1M. The position accounts for 1.03% of the portfolio, ranked #32.
GW Henssler & Associates first reported a position in MRK in Q2 2013 and has held it in 25 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- GW Henssler & Associates held 179,384 shares of Merck worth $23.1M as of Q2 2026.
- GW Henssler & Associates sold 1,663 Merck shares in Q2 2026, an estimated $195K.
- Merck made up 1.03% of GW Henssler & Associates's portfolio in Q2 2026, its #32 holding.
- GW Henssler & Associates first reported a position in Merck in Q2 2013 and has held it in 25 quarters since.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.